Skip to main content
. 2001 Jan;8(1):21–30. doi: 10.1128/CDLI.8.1.21-30.2001

TABLE 1.

Immunological characteristics and age distribution of the study groupsa

Characteristic Control Mild Severe
No. of subjects 15 27 25
White cell count (no. of cells [103]/μl) 9.0 ± 0.7 9.6 ± 0.9 7.9 ± 0.5
PMNs
 Count (no. of PMNs [103]/μl) 2.5 ± 0.2 3.7 ± 0.5 2.8 ± 0.4
 Percentage 28.6 ± 2.8 37.8 ± 2.3b 34.9 ± 2.7
CD4 cells
 Count (no. of cells/μl) by age 2,180 ± 320 1,143 ± 198b 528 ± 105b
  0–24 mo 2,819 ± 562 (n = 7) 2,909 ± 304 (n = 6) 903 ± 214 (n = 8)b
  24–60 mo 1,847 ± 335 (n = 5) 986 ± 185 (n = 9)b 448 ± 161 (n = 10)b
  60+ mo 1,244 ± 51 (n = 3) 436 ± 65 (n = 12)b 239 ± 55 (n = 7)b
 Percentage by age 38.2 ± 1.9 22.2 ± 1.8b 12.6 ± 2.4b
  0–24 mo 40.2 ± 3.2 (n = 7) 33.9 ± 1.7 (n = 6) 18.5 ± 5.2 (n = 8)b
  24–60 mo 34.8 ± 0.8 (n = 5) 25.3 ± 1.4 (n = 9)b 8.3 ± 2.6 (n = 10)b
  60+ mo 39.4 ± 6.2 (n = 3) 14.0 ± 2.3 (n = 12)b 8.9 ± 1.7 (n = 7)b
CD8 cells
 Count (no. of cells/μl) 1,468 ± 213 2,058 ± 240 2,322 ± 264b
 Percentage 26.6 ± 1.7 46.2 ± 2.5b 58.0 ± 2.9b
CD4:CD8 ratio 1.55 ± 0.15 0.60 ± 0.09b 0.26 ± 0.06b
HIV viral load (log no. of RNA copies/ml) 4.57 ± 0.15 5.33 ± 0.14
a

Results are expressed as the mean ± standard error of the mean. 

b

Significant differences (P < 0.05) when results for the mild and severe disease groups are compared to those for the control group.